Protalix BioTherapeutics, Inc. Quarterly Cost of Revenue in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Protalix BioTherapeutics, Inc. quarterly/annual Cost of Revenue history and growth rate from Q2 2010 to Q3 2024.
  • Protalix BioTherapeutics, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $8.38M, a 71.2% increase year-over-year.
  • Protalix BioTherapeutics, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $29.3M, a 77.3% increase year-over-year.
  • Protalix BioTherapeutics, Inc. annual Cost of Revenue for 2023 was $23M, a 17.3% increase from 2022.
  • Protalix BioTherapeutics, Inc. annual Cost of Revenue for 2022 was $19.6M, a 19.8% increase from 2021.
  • Protalix BioTherapeutics, Inc. annual Cost of Revenue for 2021 was $16.3M, a 50.4% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $29.3M $8.38M +$3.48M +71.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $25.8M $9.46M +$3.31M +53.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $22.5M $2.6M -$483K -15.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $23M $8.86M +$6.46M +269% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $16.5M $4.89M -$2.18M -30.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $18.7M $6.15M +$2.06M +50.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $16.6M $3.09M -$2.95M -48.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $19.6M $2.4M -$751K -23.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $20.3M $7.07M +$3.37M +91% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $17M $4.09M -$646K -13.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $17.6M $6.03M +$1.27M +26.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $16.3M $3.15M +$396K +14.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-14
Q3 2021 $16M $3.7M +$835K +29.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $15.1M $4.73M +$2.91M +159% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $12.2M $4.77M +$1.34M +39.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $10.9M $2.75M -$198K -6.71% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $11.1M $2.87M -$337K -10.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $11.4M $1.83M -$868K -32.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $12.3M $3.43M +$1.38M +67.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $10.9M $2.95M +$672K +29.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-31
Q3 2019 $10.2M $3.21M +$1.29M +67.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $8.94M $2.7M +$512K +23.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $8.42M $2.05M -$879K -30.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-01
Q4 2018 $9.3M $2.28M +$724K +46.6% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-30
Q3 2018 $8.58M $1.92M -$4.15M -68.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $12.7M $2.18M -$3.34M -60.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $16.1M $2.92M +$836K +40% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q4 2017 $15.2M $1.55M -$398K -20.4% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 $15.6M $6.07M +$1.82M +42.8% Jul 1, 2017 Sep 30, 2017 10-Q/A 2019-03-18
Q2 2017 $13.8M $5.52M +$3.85M +230% Apr 1, 2017 Jun 30, 2017 10-Q/A 2019-03-18
Q1 2017 $9.96M $2.09M +$1.57M +299% Jan 1, 2017 Mar 31, 2017 10-Q/A 2019-03-18
Q4 2016 $8.4M $1.95M +$1.95M Oct 1, 2016 Dec 31, 2016 10-K 2019-03-18
Q3 2016 $6.45M $4.25M +$4.03M +1805% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $2.42M $1.68M +$1.45M +644% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $971K $523K +$241K +85.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $730K $0 +$6.85M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-06
Q3 2015 -$6.12M $223K -$1.58M -87.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$4.54M $225K -$1.38M -86% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$3.16M $282K -$3.79M -93.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $630K -$6.85M -$2.97M -76.6% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 $3.6M $1.8M +$211K +13.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $3.39M $1.61M +$287K +21.8% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $3.1M $4.07M +$3.1M +319% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $0 -$3.88M -$5.05M -429% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-08
Q3 2013 $5.05M $1.59M -$780K -33% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $5.83M $1.32M -$1.96M -59.8% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $7.8M $971K -$349K -26.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $8.14M $1.18M +$783K +198% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 $7.36M $2.37M +$2.15M +976% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $5.21M $3.28M +$3.15M +2384% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $2.07M $1.32M +$542K +69.7% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 $1.53M $395K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-13
Q3 2011 $220K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-07
Q2 2011 $132K +$132K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-03
Q1 2011 $778K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q2 2010 $0 Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.